OpenBilldrug price receipt

NADAC week of 2026-10-14

ABIRATERONE ACETATE 500 MG TAB

For 30 tablets

Pharmacies pay

$77.83 filed

30 × $2.59443 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$663.29 filed

30 × $22.10961 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

8.5× estimated

Medicare paid 8.5× what pharmacies pay.

Part D averages every strength and form sold under “Abiraterone Acetate” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$94.50 estimated

$77.83 + $11.67 (15%) + $5.00 fee per fill = $94.50

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

ABIRATERONE ACETATE 500 MG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “abiraterone” and “abiraterone acetate”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 12 labelers (the companies named on the label) for its NDCs, among them Mylan Pharmaceuticals Inc., Dr. Reddys Laboratories Inc and Amneal Pharmaceuticals LLC.

FDA’s Established Pharmacologic Class for it is Cytochrome P450 17A1 Inhibitor.

The NADAC file of 2026-10-14 prices it under 12 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $77.83 for 30 tablets (30 × $2.59443 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 12 labelers

LabelerNDCsPharmacies pay per unit
Amneal Pharmaceuticals LLC1$2.59443 per EA filed
Amneal Pharmaceuticals NY LLC1$2.59443 per EA filed
Apotex Corp.1$2.59443 per EA filed
BluePoint Laboratories1$2.59443 per EA filed
Dr. Reddys Laboratories Inc1$2.59443 per EA filed
Florida Pharmaceutical Products, LLC1$2.59443 per EA filed
Glenmark Pharmaceuticals Inc., USA1$2.59443 per EA filed
Mylan Pharmaceuticals Inc.1$2.59443 per EA filed
NORTHSTAR RX LLC1$2.59443 per EA filed
Novadoz Pharmaceuticals LLC1$2.59443 per EA filed
Novugen Pharma (USA) LLC1$2.59443 per EA filed
Quallent Pharmaceuticals Health LLC1$2.59443 per EA filed
All 12 NDCs, with labeler and price
  • 00378-6921-91 · Mylan Pharmaceuticals Inc. · $2.59443 per EA · eff. 2026-09-23 filed
  • 43598-0468-60 · Dr. Reddys Laboratories Inc · $2.59443 per EA · eff. 2026-09-23 filed
  • 60219-1754-06 · Amneal Pharmaceuticals LLC · $2.59443 per EA · eff. 2026-09-23 filed
  • 60505-4764-06 · Apotex Corp. · $2.59443 per EA · eff. 2026-09-23 filed
  • 68001-0673-06 · BluePoint Laboratories · $2.59443 per EA · eff. 2026-09-23 filed
  • 68462-0882-60 · Glenmark Pharmaceuticals Inc., USA · $2.59443 per EA · eff. 2026-09-23 filed
  • 69238-1754-06 · Amneal Pharmaceuticals NY LLC · $2.59443 per EA · eff. 2026-09-23 filed
  • 71921-0177-06 · Florida Pharmaceutical Products, LLC · $2.59443 per EA · eff. 2026-09-23 filed
  • 72205-0285-60 · Novadoz Pharmaceuticals LLC · $2.59443 per EA · eff. 2026-09-23 filed
  • 72603-0111-01 · NORTHSTAR RX LLC · $2.59443 per EA · eff. 2026-09-23 filed
  • 82009-0140-60 · Quallent Pharmaceuticals Health LLC · $2.59443 per EA · eff. 2026-09-23 filed
  • 82293-0002-10 · Novugen Pharma (USA) LLC · $2.59443 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

2 other products in the NADAC file share an FDA nonproprietary name with ABIRATERONE ACETATE 500 MG TAB.

ProductPharmacies pay per unitMedicare per unit
ABIRATERONE ACETATE 250 MG TAB
generic · tablet / tablet, film coated
$0.77414 per EA filed
eff. 2026-09-23
$22.10961 per EA filed
Part D 2024 average
ABIRATERONE ACETATE 500 MG TAB this page
generic · tablet, film coated / tablet
$2.59443 per EA filed
eff. 2026-09-23
$22.10961 per EA filed
Part D 2024 average
ABIRTEGA 250 MG TABLET
generic · tablet
$0.77414 per EA filed
eff. 2026-09-23
$22.10961 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

Medicare Part D paid $663.29 for 30 tablets, at an average of $22.10961 per EA in 2024 (2024-01-01 to 2024-12-31) for “Abiraterone Acetate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 389,368 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

10 of the product’s 12 NDCs have this Medicare figure; the other 2 do not, and the interactive card says why for each.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for ABIRATERONE ACETATE 500 MG TAB labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Abiraterone Acetate / Abiraterone Acetate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.